View of Safety profile of COVID-19 Medication in Chronic Kidney disease patients: renal and hepatic dysfunction associated with anti-viral and Tocilizumab use. Single Centre experience

Return to Article Details Safety profile of COVID-19 Medication in Chronic Kidney disease patients: renal and hepatic dysfunction associated with anti-viral and Tocilizumab use. Single Centre experience Download Download PDF